logo
Share SHARE
FONT-SIZE Plus   Neg

Simulations Plus Sees Q2 Revenues Of $2.8 Mln

Simulations Plus, Inc. (SLP), a provider of simulation software for pharmaceutical development, said Monday that it expects revenues of $2.8 million for the second quarter of fiscal 2012, up 6.4 percent from last year's revenue of $2.6 million.

The company said that approximately 15 percent of the revenues came from new software licenses and 4 percent from consulting studies.

Walt Woltosz, chief executive officer of Simulations Plus, said, "Fiscal year 2012 continues our trend of growth and profitability with a new record for any quarter in our second quarter, layering on top of our announced record first quarter revenue. We are focused on increasing our market penetration and delivering accelerating operating leverage as incremental top-line growth drives faster bottom-line increases."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
British lender Lloyds Banking Group Plc. Friday reported higher profit in its first half, benefited by increased net interest income and margin as well as lower impairment. Looking ahead, the company lifted its net interest margin forecast. Amgen reported an increase in second-quarter profit, driven by sales of arthritis drug Enbrel and osteoporosis treatments Xgeva and Prolia, and improved margins. Both earnings and sales topped Wall Street estimates. Electronic Arts Inc. (EA) on Thursday reported an increase in profit for the first quarter, reflecting continued strong digital revenues, with both earnings and revenues topping Wall Street estimates. However, shares of the company fell over 4 percent, after having detailed a weak outlook. Redwood...
comments powered by Disqus
Follow RTT